Literature DB >> 9430659

Sesquiterpene lactones specifically inhibit activation of NF-kappa B by preventing the degradation of I kappa B-alpha and I kappa B-beta.

S P Hehner1, M Heinrich, P M Bork, M Vogt, F Ratter, V Lehmann, K Schulze-Osthoff, W Dröge, M L Schmitz.   

Abstract

Extracts from certain Mexican Indian medicinal plants used in traditional indigenous medicine for the treatment of inflammations contain sequiterpene lactones (SLs), which specifically inhibit the transcription factor NF-kappa B (Bork, P. M., Schmitz, M. L., Kuhnt, M., Escher, C., and Heinrich, M. (1997) FEBS Lett. 402, 85-90). Here we show that SLs prevented the activation of NF-kappa B by different stimuli such as phorbol esters, tumor necrosis factor-alpha, ligation of the T-cell receptor, and hydrogen peroxide in various cell types. Treatment of cells with SLs prevented the induced degradation of I kappa B-alpha and I kappa B-beta by all these stimuli, suggesting that they interfere with a rather common step in the activation of NF-kappa B. SLs did neither interfere with DNA binding activity of activated NF-kappa B nor with the activity of the protein tyrosine kinases p59fyn and p60arc. Micromolar amounts of SLs prevented the induced expression of the NF-kappa B target gene intracellular adhesion molecule 1. Inhibition of NF-kappa B by SLs resulted in an enhanced cell killing of murine fibroblast cells by tumor necrosis factor-alpha. SLs lacking an exomethylene group in conjugation with the lactone function displayed no inhibitory activity on NF-kappa B. The analysis of the cellular redox state by fluorescence-activated cell sorter showed that the SLs had no direct or indirect anti-oxidant properties.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9430659     DOI: 10.1074/jbc.273.3.1288

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  81 in total

1.  The use of small molecule probes to study spatially separated stimulus-induced signaling pathways.

Authors:  Vladimir V Kravchenko; Christian Gloeckner; G Neil Stowe; Young J Kang; Peter S Tobias; John C Mathison; Richard J Ulevitch; Gunnar F Kaufmann; Kim D Janda
Journal:  Bioorg Med Chem Lett       Date:  2012-01-14       Impact factor: 2.823

2.  The effect of dehydroleucodine in adipocyte differentiation.

Authors:  Adriana Galvis; Adriana Marcano; Chad Stefancin; Nicole Villaverde; Horacio A Priestap; Carlos E Tonn; Luis A Lopez; Manuel A Barbieri
Journal:  Eur J Pharmacol       Date:  2011-09-19       Impact factor: 4.432

3.  Chemoenzymatic synthesis and antileukemic activity of novel C9- and C14-functionalized parthenolide analogs.

Authors:  Vikas Tyagi; Hanan Alwaseem; Kristen M O'Dwyer; Jessica Ponder; Qi Ying Li; Craig T Jordan; Rudi Fasan
Journal:  Bioorg Med Chem       Date:  2016-06-16       Impact factor: 3.641

4.  Contribution of a nuclear factor-kappaB binding site to human angiotensinogen promoter activity in renal proximal tubular cells.

Authors:  Omar W Acres; Ryousuke Satou; L Gabriel Navar; Hiroyuki Kobori
Journal:  Hypertension       Date:  2011-01-31       Impact factor: 10.190

5.  Heterocyclic aminoparthenolide derivatives modulate G(2)-M cell cycle progression during Xenopus oocyte maturation.

Authors:  Venumadhav Janganati; Narsimha Reddy Penthala; Chad E Cragle; Angus M MacNicol; Peter A Crooks
Journal:  Bioorg Med Chem Lett       Date:  2014-03-04       Impact factor: 2.823

6.  Identification of a melampomagnolide B analog as a potential lead molecule for treatment of acute myelogenous leukemia.

Authors:  Zaineb A F Albayati; Venumadhav Janganati; Zheng Chen; Jessica Ponder; Philip J Breen; Craig T Jordan; Peter A Crooks
Journal:  Bioorg Med Chem       Date:  2016-12-26       Impact factor: 3.641

7.  Discovery of potent parthenolide-based antileukemic agents enabled by late-stage P450-mediated C-H functionalization.

Authors:  Joshua N Kolev; Kristen M O'Dwyer; Craig T Jordan; Rudi Fasan
Journal:  ACS Chem Biol       Date:  2013-11-08       Impact factor: 5.100

8.  Parthenolide inhibits IkappaB kinase, NF-kappaB activation, and inflammatory response in cystic fibrosis cells and mice.

Authors:  Aicha Saadane; Sophia Masters; Joseph DiDonato; Jingfeng Li; Melvin Berger
Journal:  Am J Respir Cell Mol Biol       Date:  2007-02-01       Impact factor: 6.914

9.  Activation of common antiviral pathways can potentiate inflammatory responses to septic shock.

Authors:  Lesley A Doughty; Stacey Carlton; Benjamin Galen; Indranie Cooma-Ramberan; Chung-Shiang Chung; Alfred Ayala
Journal:  Shock       Date:  2006-08       Impact factor: 3.454

Review 10.  Phytochemicals as potential antidotes for targeting NF-κB in rheumatoid arthritis.

Authors:  R Kowshik Aravilli; S Laveen Vikram; V Kohila
Journal:  3 Biotech       Date:  2017-07-18       Impact factor: 2.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.